Slide Deck for Urologists: Templates for Every Patient Conversation

Urology covers an extraordinary range of clinical scenarios — from a worried 55-year-old man with an elevated PSA to a woman with refractory overactive bladder to a teenager passing their first kidney stone. Each requires a completely different patient education approach. A slide deck for urologists structures these conversations, ensures consistent information delivery, reduces patient anxiety, and supports informed decision-making.

Slide-deck.io is a free, browser-based presentation builder that lets urologists and urology group practices create professional patient education decks, surgical consent presentations, and shared decision-making tools without design software or a dedicated communications team.

Prostate Cancer: The Most Complex Decision in Men's Health

No clinical scenario in urology demands more careful communication than prostate cancer. The decision between active surveillance, surgery, radiation, and other modalities is highly individualized — and patients who don't understand the decision framework make choices they later regret.

PSA Screening Debate

Men coming in for PSA screening or with a recent elevated PSA result need context. A screening education deck covers: what PSA measures (prostate-specific antigen, a protein produced by both normal and cancerous prostate cells), what an elevated PSA means and doesn't mean (many causes including BPH, prostatitis, and physical activity), the USPSTF recommendation (shared decision-making for men ages 55–69; the 2018 update moved from a D recommendation to a C recommendation), and the AUA recommendation (discussion of benefits and harms of screening for appropriate men from age 40–45 depending on risk factors). Be clear that guidelines reflect population-level risk-benefit tradeoffs and that individual risk factors modify these recommendations.

Biopsy Process

When biopsy is indicated, a pre-procedure education deck covers: transrectal ultrasound (TRUS)-guided biopsy vs. MRI-fusion biopsy (the superiority of MRI-targeted biopsy for clinically significant cancer detection warrants explicit discussion), the number of cores taken, procedural discomfort (what to expect: pressure, occasional sharp sensation), after-procedure expectations (blood in urine/semen/stool for up to 6 weeks — mention this proactively to avoid alarmed calls), prophylactic antibiotic protocol, and infection warning signs requiring immediate evaluation.

Gleason Score/Grade Group Explanation

Gleason grading is the single most confusing element of prostate cancer diagnosis for patients. A dedicated explanation slide covers: the Gleason scoring system (two numbers, each from 1–5, added together), the shift to Grade Groups (Grade Group 1 = Gleason 6, Grade Group 2 = Gleason 3+4=7, Grade Group 3 = Gleason 4+3=7, Grade Group 4 = Gleason 8, Grade Group 5 = Gleason 9–10), what this patient's grade means in terms of aggressiveness, and why Grade Group is used to guide treatment decisions.

Risk Stratification

The treatment decision framework flows from risk stratification:

• Very Low Risk (Grade Group 1, PSA <10, clinical stage T1c, <3 positive cores, <50% cancer in any core): active surveillance is strongly preferred
• Low Risk (Grade Group 1, PSA <10, clinical stage T1–T2a): active surveillance preferred; surgery or radiation for those who choose treatment
• Favorable Intermediate Risk (Grade Group 2, PSA 10–20 or clinical stage T2b): active surveillance for appropriate candidates; surgery or radiation with or without short-term ADT
• Unfavorable Intermediate Risk (Grade Group 3 or multiple intermediate features): surgery or radiation with 4–6 months ADT
• High/Very High Risk (Grade Group 4–5 or PSA >20 or clinical stage T3–T4): radiation with long-term ADT, surgery for carefully selected patients, systemic therapy combinations

Treatment Options Matrix

A side-by-side comparison slide covering active surveillance (monitoring protocol, PSA frequency, biopsy interval, when to escalate), radical prostatectomy (open vs. robotic-assisted — your center's approach, nerve-sparing criteria, lymph node dissection), external beam radiation (conventional fractionation vs. stereotactic body radiation therapy — treatment duration differences are significant quality-of-life considerations for patients), brachytherapy (low dose rate vs. high dose rate), and androgen deprivation therapy (when used, mechanism, side effects — sexual function, hot flashes, bone density, metabolic effects).

Side Effect Comparison Chart

Patients ultimately make this decision based on which side effects they're most willing to risk. A transparent side effect comparison — incontinence risk (higher immediately post-surgery, equivalent at 1–2 years), erectile dysfunction risk (higher with surgery; radiation-related ED develops more gradually), bowel toxicity (radiation-specific), and urinary toxicity (radiation-specific urethral stricture risk, surgery-specific) — with rates drawn from current published literature enables genuinely informed consent.

Benign Prostatic Hyperplasia: Symptom Scoring and Treatment Options

BPH is one of the most common conditions managed by urologists. A BPH education deck covers:

• IPSS/AUA Symptom Score: walk the patient through their score (mild 0–7, moderate 8–19, severe 20–35) and explain what each domain measures
• Medical therapy: alpha-blockers (tamsulosin, alfuzosin — mechanism: smooth muscle relaxation in bladder neck and prostate, onset within days, orthostatic hypotension risk), 5-alpha reductase inhibitors (finasteride, dutasteride — mechanism: reduces prostate volume over 3–6 months, sexual side effects, PSA reduction of approximately 50%), combination therapy for larger prostates
• Minimally invasive surgical therapies: UroLift (prostatic urethral lift — procedural details, sexual function preservation, typical outcomes), Rezūm (water vapor thermal therapy — mechanism, recovery timeline), iTIND (temporary implantable nitinol device)
• Surgical options: transurethral resection of the prostate (TURP), laser enucleation (HoLEP, ThuLEP) — when each is indicated, expected outcomes, risk profile

Kidney Stone Prevention: The 24-Hour Urine Analysis

Patients who have passed one kidney stone have a 50% likelihood of recurrence within 10 years. Metabolic evaluation identifies the stone type and underlying cause, enabling targeted prevention.

Interpreting 24-Hour Urine Results

A patient-facing results interpretation deck covers: what was measured (urine volume, pH, calcium, oxalate, uric acid, citrate, sodium, potassium, magnesium, phosphorus, creatinine), what each parameter means, and this patient's specific abnormalities. Then connect each abnormality to a specific dietary or medication intervention:

• Calcium oxalate stones (most common, ~75%): low-oxalate diet guidance (specific high-oxalate foods to limit: spinach, rhubarb, almonds, beets), adequate calcium intake (dietary calcium, not supplements, actually reduces stone risk by binding oxalate in the gut), hydration target (urine output >2.5 liters/day), reduced sodium intake (increases urinary calcium excretion)
• Uric acid stones: low-purine diet (limit red meat, organ meats, shellfish, high-fructose corn syrup), alkalinize urine with potassium citrate (target urine pH 6.0–6.5), weight management and diabetes control (insulin resistance drives uric acid retention)
• Calcium phosphate stones: identify and treat hypercalciuria causes (hyperparathyroidism, distal renal tubular acidosis), reduce sodium intake, reduce protein intake if hypercalciuric
• Struvite stones: infection-related (Proteus mirabilis and other urease-producing organisms), treatment focuses on complete stone removal and treatment of underlying UTI

Daily Hydration Target

The single most impactful prevention measure across all stone types is hydration. A simple visual — showing the urine color chart and the target (pale yellow/lemonade color, corresponding to >2.5L urine output) — is more actionable than telling a patient to "drink more water."

Overactive Bladder: Behavioral to Neuromodulation

OAB affects approximately 33 million adults in the United States. A treatment options deck covers the stepwise approach:

• Behavioral interventions (first-line): bladder training (voiding schedule with progressive interval extension), urgency suppression techniques (urge deferral, distraction, pelvic floor contraction), fluid management (caffeine elimination, evening fluid reduction), weight loss in appropriate patients
• Pelvic floor physical therapy: for patients with concurrent pelvic floor dysfunction; what to expect in PT
• Pharmacological management: anticholinergics (oxybutynin, tolterodine, solifenacin — mechanism, cognitive effects in elderly patients — the black box context, constipation management) vs. beta-3 agonists (mirabegron, vibegron — mechanism, cardiovascular considerations, fewer cognitive effects)
• Intravesical botulinum toxin: intradetrusor injection — procedure details, onset (2–4 weeks), duration (6–12 months), self-catheterization risk and how to assess candidacy, AUA criteria for use
• Percutaneous tibial nerve stimulation (PTNS): mechanism (neuromodulation via S3 pathway through tibial nerve), weekly office-based treatment for 12 weeks, maintenance schedule
• Sacral neuromodulation (InterStim): staged implantation (trial period first), mechanism, patient selection, battery longevity, MRI compatibility

Cystoscopy Consent Presentation

Cystoscopy — whether diagnostic (evaluate hematuria, recurrent UTI, bladder symptoms) or procedural — benefits from a visual consent presentation. Cover: the procedure (flexible or rigid scope via urethra, direct visualization of urethra, bladder, ureteral orifices), what you're looking for, topical anesthetic gel vs. additional sedation, duration (typically 5–15 minutes in-office), discomfort during vs. post-procedure, post-procedure instructions (increased fluid intake, possible brief dysuria, hematuria), and when to call (fever, significant hematuria, inability to void).

Prostate Biopsy Consent Presentation

In addition to procedure education, the consent presentation covers: results timeline (typically 3–7 business days), how results will be communicated, next steps if biopsy is negative (continued surveillance plan based on PSA kinetics and biopsy indication), and next steps if biopsy is positive (scheduling consultation, what questions to bring).

Male Sexual Health Consultation

Erectile dysfunction affects approximately 30 million American men. A consultation deck for male sexual health covers: the evaluation framework (identifying vasculogenic, neurogenic, hormonal, psychogenic, and medication-related causes), the role of testosterone evaluation, treatment options:

• PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil): mechanism (nitric oxide pathway, smooth muscle relaxation, increased penile blood flow), onset and duration by agent, food and alcohol interactions, contraindication with nitrates, cardiac clearance considerations
• Vacuum erection device: mechanism, how to use, realistic expectations for satisfaction and sustainability
• Penile injection therapy (alprostadil, trimix): mechanism, self-injection technique, priapism protocol (what to do if erection persists beyond 4 hours — this must be stated explicitly)
• Penile prosthesis: inflatable vs. malleable, who is a candidate, satisfaction rates (highest of any ED treatment at approximately 95% among implant recipients), surgical considerations

Include realistic expectations by severity and age — patients who understand why their response to PDE5 inhibitors may be incomplete (severe vascular disease, post-radical prostatectomy nerve injury) make better decisions about next-step treatments.

Building Urology Presentations on slide-deck.io

Slide-deck.io is free, browser-based, and built for the complexity that urology consultations demand. Build prostate cancer shared decision-making decks that patients take home and discuss with family before their next appointment. Create BPH treatment comparison slides that make the step-up approach self-evident. Share kidney stone prevention plans by link so patients have their dietary instructions on their phone.

Urology involves some of the most sensitive and consequential medical decisions men and women face. Your presentation tools should reflect the seriousness of those conversations.